MANE ▼ -5.5% - Veradermics, Incorporated
$MANE - Veradermics to Hold Conference Call to Discuss Topline Results from Phase 3 ‘304’ Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
18-OCT-2026 06:06 PM ET
Share this post
More filings for $MANE
MANE - Veradermics, Incorporated - SEC Filing Update (13-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 13, 2026MANE ▼ -0.0% - Veradermics, IncorporatedSep 3, 2026MANE - Veradermics, Incorporated - SEC Filing Update (21-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 21, 2026MANE - Veradermics, Incorporated - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 15, 2026MANE - Veradermics, Incorporated - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026
View full $MANE filing history →💬 Comments
Loading comments…
Leave a comment